Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 63 results:
Author Title Type [ Year] Filters: Keyword is Renal Insufficiency, Chronic [Clear All Filters]
Combination therapy with an SGLT-2 inhibitor and finerenone in DKD: Are we there yet?.
Eur J Clin Invest. 53(2), e13864.
(2023). N-Acetylcysteine: more than preventing contrast-induced nephropathy in uremic patients-focus on the antioxidant and anti-inflammatory properties..
Int Urol Nephrol. 55(6), 1481-1492.
(2023). Redox Systems Biology in Chronic Kidney Disease..
Oxid Med Cell Longev. 2023, 9864037.
(2023). Therapeutic Advances in Diabetic Kidney Disease..
Int J Mol Sci. 24(3),
(2023). Which blood pressure threshold indicates a therapeutic benefit for patients with chronic kidney disease?.
Hypertens Res. 46(4), 890-892.
(2023). Tenofovir alafenamide prophylaxis post-liver transplantation: a real-world study in patients with chronic kidney disease..
Acta Gastroenterol Belg. 85(2), 331-337.
(2022). KDIGO made 12 recommendations for managing diabetes with CKD..
Ann Intern Med. 174(3), JC26.
(2021). Determination of the glomerular filtration rate in patients with type 2 diabetes: An assessment of the agreement between Cr-EDTA plasma clearance and Tc-DTPA plasma clearance, Tc-DTPA renography and plasma creatinine prediction equation..
Diabetes Res Clin Pract. 161, 108079.
(2020). Kidney health for everyone everywhere - from prevention to detection and equitable access to care..
Clin Nephrol. 93(3), 111-122.
(2020). Kidney health for everyone everywhere - from prevention to detection and equitable access to care..
Braz J Med Biol Res. 53(3), e9614.
(2020). Kidney Health for Everyone Everywhere - from Prevention to Detection and Equitable Access to Care..
West Afr J Med. 37(4), 368-376.
(2020). Kidney Health for Everyone Everywhere-From Prevention to Detection and Equitable Access to Care..
J Ren Care. 46(1), 4-12.
(2020). Pharmacotherapy of hypertension in patients with pre-dialysis chronic kidney disease..
Expert Opin Pharmacother. 21(10), 1201-1217.
(2020). Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review..
Int J Mol Sci. 20(3),
(2019). Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial..
Lancet. 393(10184), 1937-1947.
(2019). Body composition and arterial stiffness in pediatric patients with chronic kidney disease..
Pediatr Nephrol. 34(7), 1253-1260.
(2019). Dietary Antioxidant Supplements and Uric Acid in Chronic Kidney Disease: A Review..
Nutrients. 11(8),
(2019). Effects of mineralocorticoid receptor antagonists in proteinuric kidney disease: a systematic review and meta-analysis of randomized controlled trials..
J Hypertens. 37(12), 2307-2324.
(2019). Increased Sclerostin, but Not Dickkopf-1 Protein, Is Associated with Elevated Pulse Wave Velocity in Hemodialysis Subjects..
Kidney Blood Press Res. 44(4), 679-689.
(2019). Infants with congenital nephrotic syndrome have comparable outcomes to infants with other renal diseases..
Pediatr Nephrol. 34(4), 649-655.
(2019). Letter to the Editor: "Familial Hypercholesterolemia and Risk of Peripheral Arterial Disease and Chronic Kidney Disease"..
J Clin Endocrinol Metab. 104(8), 3124.
(2019). Is oxidative stress an issue in peritoneal dialysis?.
Semin Dial. 32(5), 463-466.
(2019). Oxidative Stress in the Pathogenesis and Evolution of Chronic Kidney Disease: Untangling Ariadne's Thread..
Int J Mol Sci. 20(15),
(2019).
(2019).
(2019).